Novogast (Omeprazole)

Omeprazole, the active ingredient in Novogast, is a Proton Pump Inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children.

GNH USA supplies Novogast as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): Improves symptom relief and promotes healing of the esophageal lining. - Peptic ulcer disease: Facilitates ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: Controls excess gastric acid production. - Erosive esophagitis: Aids mucosal healing and symptom control. - NSAID‑induced ulcer prophylaxis: Lowers risk of ulcer development in at‑risk patients.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Headache: mild, transient headache. - Diarrhea: loose stools, often self‑limiting. - Abdominal pain: mild discomfort in the stomach area. - Nausea: occasional feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Acute interstitial nephritis: kidney inflammation with possible renal impairment. - Hypomagnesemia: low serum magnesium causing muscle cramps or cardiac arrhythmia. - Stevens‑Johnson syndrome: rare skin and mucous membrane reaction. - Hepatic injury: elevated liver enzymes or hepatitis. - Fracture risk: potential decrease in bone mineral density with long‑term use.

Before initiating therapy, consider the following safety measures: - Assess renal function: adjust use in patients with severe renal impairment. - Review hepatic status: use cautiously in liver disease. - Evaluate infection risk: monitor for Clostridioides difficile if prolonged therapy is planned. - Pregnancy and lactation: weigh benefits against potential risks; consult obstetric guidance. - Drug‑interaction review: check concomitant medications for possible interactions. - Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture.

Omeprazole may interact with several medicines; careful management is advised.

Major Interactions (Avoid): - Antifungal azoles (e.g., ketoconazole): reduced absorption of omeprazole. - Clopidogrel: decreased antiplatelet effect, increasing cardiovascular risk. - Atorvastatin: increased plasma concentration, raising risk of myopathy.

Moderate Interaction ​​  : - Warfarin: may alter   t   t  t ",